Disease management

It is currently conducting clinical studies and expanding its teams in Australia and the US.

Receiving opioid use disorder-related telehealth services during the COVID-19 pandemic was associated with lower odds of overdose and better retention using medications like buprenorphine, according to a study published in JAMA Psychiatry.

Augment Health cofounders Jared Meyers and Stephen Kalinsky describe their device that aims to improve the quality of life for people with bladder-control issues stemming from brain, spinal cord or nerve problems.

During a panel at the Connected Health Summit, participants discussed the growth of remote patient monitoring technology and how providers can encourage its use, particularly among seniors.

The startup plans to use the funding to expand in the U.S.

It is a home-based programme with 10 self-paced modules.

Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.

One of the projects will develop a digital navigator to support people with chronic conditions.

Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.

Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.